Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)

Joseph M. Paris, Kathryn Cunningham

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Systemic administration of 3,4-methylenedioxymethamphetamine (MDMA) produces depletions of serotonin (5-HT) and its primary metabolite, 5-hydroxyindoleacetic acid (5-HIAA), decreases 5-HT reuptake sites and diminishes tryptophan hydroxylase activity in various forebrain regions. MDMA has been shown to be neurotoxic to the fine fibers originating from dorsal raphe (DR) 5-HT neurons but not the beaded fibers from the median raphe (MR) nucleus. In the present experiment, MDMA was microinjected directly into the DR or MR to determine whether differential neurotoxicity developed in the DR versus MR fiber systems as measured by 5-HT levels and immunocytochemistry. Two weeks following stereotaxic injection with either vehicle or ( + )MDMA (50 μ,g base in 2 μ1) into the DR or MR, rat brains were assayed for 5-HT and catecholamine content or 5-HT immunocytochemistry. HPLC analysis revealed no significant changes in monoamine or metabolite concentrations in the hippocampus and striatum of rats administered intra-DR or -MR ( + )MDMA. Raphe sections stained for 5-HT also did not reveal any apparent neurotoxicity. A single cerebral injection of ( + )MDMA does not produce neurotoxicity to 5-HT neuronal systems originating in the raphe, although neurotoxicity of multiple MDMA injections into these raphe nuclei cannot be ruled out.

Original languageEnglish (US)
Pages (from-to)115-119
Number of pages5
JournalBrain Research Bulletin
Volume28
Issue number1
DOIs
StatePublished - 1992

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Microinjections
Serotonin
Raphe Nuclei
Injections
Immunohistochemistry
Tryptophan Hydroxylase
Hydroxyindoleacetic Acid
Prosencephalon
Catecholamines
Hippocampus
High Pressure Liquid Chromatography
Dorsal Raphe Nucleus
Neurons

Keywords

  • 3,4-Methylenedioxymethamphetamine (MDMA)
  • Dorsal raphe
  • Median raphe
  • Microinjections
  • Neurotoxicity
  • Rat
  • Serotonin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). / Paris, Joseph M.; Cunningham, Kathryn.

In: Brain Research Bulletin, Vol. 28, No. 1, 1992, p. 115-119.

Research output: Contribution to journalArticle

@article{8831539db06b47eba5c13ea95ec11601,
title = "Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)",
abstract = "Systemic administration of 3,4-methylenedioxymethamphetamine (MDMA) produces depletions of serotonin (5-HT) and its primary metabolite, 5-hydroxyindoleacetic acid (5-HIAA), decreases 5-HT reuptake sites and diminishes tryptophan hydroxylase activity in various forebrain regions. MDMA has been shown to be neurotoxic to the fine fibers originating from dorsal raphe (DR) 5-HT neurons but not the beaded fibers from the median raphe (MR) nucleus. In the present experiment, MDMA was microinjected directly into the DR or MR to determine whether differential neurotoxicity developed in the DR versus MR fiber systems as measured by 5-HT levels and immunocytochemistry. Two weeks following stereotaxic injection with either vehicle or ( + )MDMA (50 μ,g base in 2 μ1) into the DR or MR, rat brains were assayed for 5-HT and catecholamine content or 5-HT immunocytochemistry. HPLC analysis revealed no significant changes in monoamine or metabolite concentrations in the hippocampus and striatum of rats administered intra-DR or -MR ( + )MDMA. Raphe sections stained for 5-HT also did not reveal any apparent neurotoxicity. A single cerebral injection of ( + )MDMA does not produce neurotoxicity to 5-HT neuronal systems originating in the raphe, although neurotoxicity of multiple MDMA injections into these raphe nuclei cannot be ruled out.",
keywords = "3,4-Methylenedioxymethamphetamine (MDMA), Dorsal raphe, Median raphe, Microinjections, Neurotoxicity, Rat, Serotonin",
author = "Paris, {Joseph M.} and Kathryn Cunningham",
year = "1992",
doi = "10.1016/0361-9230(92)90237-R",
language = "English (US)",
volume = "28",
pages = "115--119",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)

AU - Paris, Joseph M.

AU - Cunningham, Kathryn

PY - 1992

Y1 - 1992

N2 - Systemic administration of 3,4-methylenedioxymethamphetamine (MDMA) produces depletions of serotonin (5-HT) and its primary metabolite, 5-hydroxyindoleacetic acid (5-HIAA), decreases 5-HT reuptake sites and diminishes tryptophan hydroxylase activity in various forebrain regions. MDMA has been shown to be neurotoxic to the fine fibers originating from dorsal raphe (DR) 5-HT neurons but not the beaded fibers from the median raphe (MR) nucleus. In the present experiment, MDMA was microinjected directly into the DR or MR to determine whether differential neurotoxicity developed in the DR versus MR fiber systems as measured by 5-HT levels and immunocytochemistry. Two weeks following stereotaxic injection with either vehicle or ( + )MDMA (50 μ,g base in 2 μ1) into the DR or MR, rat brains were assayed for 5-HT and catecholamine content or 5-HT immunocytochemistry. HPLC analysis revealed no significant changes in monoamine or metabolite concentrations in the hippocampus and striatum of rats administered intra-DR or -MR ( + )MDMA. Raphe sections stained for 5-HT also did not reveal any apparent neurotoxicity. A single cerebral injection of ( + )MDMA does not produce neurotoxicity to 5-HT neuronal systems originating in the raphe, although neurotoxicity of multiple MDMA injections into these raphe nuclei cannot be ruled out.

AB - Systemic administration of 3,4-methylenedioxymethamphetamine (MDMA) produces depletions of serotonin (5-HT) and its primary metabolite, 5-hydroxyindoleacetic acid (5-HIAA), decreases 5-HT reuptake sites and diminishes tryptophan hydroxylase activity in various forebrain regions. MDMA has been shown to be neurotoxic to the fine fibers originating from dorsal raphe (DR) 5-HT neurons but not the beaded fibers from the median raphe (MR) nucleus. In the present experiment, MDMA was microinjected directly into the DR or MR to determine whether differential neurotoxicity developed in the DR versus MR fiber systems as measured by 5-HT levels and immunocytochemistry. Two weeks following stereotaxic injection with either vehicle or ( + )MDMA (50 μ,g base in 2 μ1) into the DR or MR, rat brains were assayed for 5-HT and catecholamine content or 5-HT immunocytochemistry. HPLC analysis revealed no significant changes in monoamine or metabolite concentrations in the hippocampus and striatum of rats administered intra-DR or -MR ( + )MDMA. Raphe sections stained for 5-HT also did not reveal any apparent neurotoxicity. A single cerebral injection of ( + )MDMA does not produce neurotoxicity to 5-HT neuronal systems originating in the raphe, although neurotoxicity of multiple MDMA injections into these raphe nuclei cannot be ruled out.

KW - 3,4-Methylenedioxymethamphetamine (MDMA)

KW - Dorsal raphe

KW - Median raphe

KW - Microinjections

KW - Neurotoxicity

KW - Rat

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=0026598872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026598872&partnerID=8YFLogxK

U2 - 10.1016/0361-9230(92)90237-R

DO - 10.1016/0361-9230(92)90237-R

M3 - Article

VL - 28

SP - 115

EP - 119

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 1

ER -